These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 36470642)

  • 41. The association of urine osmolality with decreased kidney function and/or albuminuria in the United States.
    Kitiwan BK; Vasunilashorn SM; Baer HJ; Mukamal K; Juraschek SP
    BMC Nephrol; 2021 Sep; 22(1):306. PubMed ID: 34507548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
    Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
    Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
    BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS; Rebholz CM; Zheng Z; Hurwitz S; Hsu CY; Feldman HI; Xie D; Liu KD; Mifflin TE; Eckfeldt JH; Kimmel PL; Vasan RS; Bonventre JV; Inker LA; Coresh J;
    Am J Kidney Dis; 2018 Oct; 72(4):538-546. PubMed ID: 30031564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Timing of Dialysis Initiation on Mortality in Patients with Peritoneal Dialysis.
    Kim HW; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    Perit Dial Int; 2015 Dec; 35(7):703-11. PubMed ID: 25292405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-protein diet is inversely related to the incidence of chronic kidney disease in middle-aged and older adults: results from a community-based prospective cohort study.
    Kwon YJ; Park K; Lee JH
    Eur J Nutr; 2022 Oct; 61(7):3795-3807. PubMed ID: 35947164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Lower Limit of Reference of Urinary Albumin/Creatinine Ratio and the Risk of Chronic Kidney Disease Progression in Patients With Type 2 Diabetes Mellitus.
    Tang WH; Hung WC; Wang CP; Wu CC; Hsuan CF; Yu TH; Hsu CC; Cheng YA; Chung FM; Lee YJ; Lu YC
    Front Endocrinol (Lausanne); 2022; 13():858267. PubMed ID: 35721762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain.
    Escobar C; Aranda U; Palacios B; Capel M; Sicras A; Sicras A; Hormigo A; Alcázar R; Manito N; Botana M
    Nefrologia (Engl Ed); 2021; 41(6):670-688. PubMed ID: 36165157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the glomerular filtration rate and tubular dysfunction in an elderly population with normoalbuminuria in China.
    Wang H; Lou Y; Ma Y; Shan X
    Clin Chim Acta; 2019 Aug; 495():377-381. PubMed ID: 31078567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subendocardial Viability Ratio Is Impaired in Highly Proteinuric Chronic Kidney Disease Patients With Low Estimated Glomerular Filtration Rate.
    Ekart R; Šegula A; Hartman T; Hojs N; Hojs R
    Ther Apher Dial; 2016 Jun; 20(3):281-5. PubMed ID: 27312916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A
    Waijer SW; Gansevoort RT; Bakris GL; Correa-Rotter R; Hou FF; Kohan DE; Kitzman DW; Makino H; McMurray JJV; Perkovic V; Tobe S; Parving HH; de Zeeuw D; Heerspink HJL
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1824-1832. PubMed ID: 34853062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Albuminuria predicts early neurological deterioration in patients with acute ischemic stroke.
    Kanamaru T; Suda S; Muraga K; Okubo S; Watanabe Y; Tsuruoka S; Kimura K
    J Neurol Sci; 2017 Jan; 372():417-420. PubMed ID: 27836107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.